Association Between Free Fatty Acid (FFA) and Insulin Resistance: The Role of Inflammation (Adiponectin and high sensivity C-reactive Protein/hs-CRP) and Stress Oxidative (Superoxide Dismutase/SOD) in Obese Non-Diabetic Individual

Indriyanti Rafi Sukmawati, Marsetio Donoseputro, Widjaja Lukito

Abstract


BACKGROUND: Obesity is highly related to insulin resistance, therefore, the increased number of obesity is followed by the increased prevalence of type 2 Diabetes Melitus. Obesity is associated with increased of reactive oxygen species (ROS) in muscle, liver and endothelial cells. The increase of ROS would lead to insulin resistance (IR) and increased proinflamatory protein. FFA plays an important role in IR by inhibiting muscle glucose transport and oxidation via effects on serin/threonine phosphorylation of IRS-1. The aim of this study was discover the existence of SOD, hs-CRP and and adiponectin levels towards the occurrence of insulin resistance which was caused by elevated level of FFA and to discover the interaction between SOD, hs-CRP and adiponectin in non diabetic obese adult male.

METHOD: This was observational study with cross sectional design. There were 65 obese male non diabetic subjects and 45 non obese male non diabetic subjects who met the criteria. In this study, measurements were done on body mass index (BMI), fasting glucose, insulin, adiponectin, hs-CRP and SOD. Obese was defined as BMI >25 kg/m2, normal weight was defined as BMI 18.5-23 kh/m2 and Insulin Resistance was defined as HOMA-IR >1.

RESULT: This study showed that Hypoadiponectinemia condition, decreased SOD level and high level of hs-CRP is associated with insulin resistance in obese non diabetic subject. Adiponectin and SOD were correlated negatively with insulin resistance in obese non diabetic (Adiponectin, r=-0.455, p<0.001; SOD, r=-0.262, p=0.003), hs-CRP was positively correlated with insulin resistance in obese non diabetic (r=0.592, p<0.001). FFA levels was increased in obese insulin resistance compared with non obese non insulin resistance. The Odds Ratio of Adiponectin, hs-CRP and SOD in this study was analyzed by logistic binary. The OR for SOD 3.6 (p=0.001), hs-CRP 9.1 (p<0.001) and Adiponectin 7.2 (p<0.001).

CONCLUSION: This study suggested that FFA levels  increased in obese insulin resistance as compared with non obese non insulin resistance. Hypoadiponectinemia, decreased SOD and elevated hs-CRP were associated with insulin resistance in obese non diabetic subjects.

KEYWORDS: obesity, insulin resistance, FFA, SOD, hs-CRP, adiponectin


Full Text:

PDF

References


Boden G. Free fatty acids as target for therapy. Curr Opin Endocrinol Diab. 2004; 11: 258-63, CrossRef.

Boden G. Obesity and free fatty acids. Endocrinol Metab Clin North Am. 2008; 37: 635-46, CrossRef.

Ceriello A, Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol. 2004; 24: 816-23, CrossRef

Ealovega MW, Tabaei BP, Brandle M, Burke R, Herman WH. Opportunistic screening for diabetes in routine clinical practice. Diab Care. 2003; 27: 9-12, CrossRef.

Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocrine Reviews. 2002; 23: 599-622, CrossRef.

Goldstein BJ, Mahadev K, Wu X. Redox paradox: insulin action is facilitated by insulin-stimulated reactive cxygen species with multiple potential signaling targets. Diabetes. 2005; 54: 311-21, CrossRef.

Grundy SM. Obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab. 2004; 89: 2595-600, CrossRef.

Kadowaki T, Hara K, Yamauchi T, Terauchi Y, Tobe K, Nagai R. Molecular mechanism of insulin resistance and obesity. Exp Biol Med. 2003; 228: 1111-7, PMID

McClung JP, Roneker CA, Mu W, Lisk DJ, Langlais P, Liu F, et al. Development of insulin resistance and obesity in mice overexpressing cellular glutathione peroxidase. Proceedings of the National Academy of Sciences. 2004; 101: 8852-7, CrossRef.

Moore PC, Ugas MA, Hagman DK, Parazzoli SD, Poitout V. Evidence against the involvement of oxidative stress in fatty acid inhibition of insulin secretion. Diabetes. 2004; 53: 2610-6, CrossRef.

Pankow JS, Duncan BB, Schmidt MI, Ballantyne CM, Couper DJ, Hoogeveen RC, et al. Fasting plasma free fatty acids and risk of type 2 diabetes: The atherosclerosis risk in communities study. Diabetes Care. 2003; 27: 77-82, CrossRef.

Roden M. How free fatty acids inhibit glucose utilization in human skeletal muscle. News Physiol Sci. 2004; 19: 92-6, CrossRef.

Tripathy D, Mohanty P, Dhindsa S, Syed T, Ghanim H, Aljada A, et al. Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects. Diabetes. 2003; 52: 2882-7, CrossRef.

Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003; 112: 1796-808, CrossRef.

Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003; 112: 1821-30, CrossRef.




DOI: https://doi.org/10.18585/inabj.v1i3.102

Indexed by:

                 

                

                

  

 

The Prodia Education and Research Institute